A groundbreaking study from Baylor College of Medicine explores how two types of CAR T cells target cancer, shedding light on ...

A study explores the molecular dynamics of CD28.ζ-CAR and 4-1BB.ζ-CAR T cells at the immune synapse, where CAR T cells bind ...

Because tumor cells are known to induce T-cell ... CAR transmembrane domain to enhance the immune synapse, offers an avenue for enhancing CAR-T therapy. By optimizing the immune synapse without ...

A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the immune synapse -- where ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

CAR T cell therapy revolutionizes oncology by using engineered T cells to target and eliminate cancer cells, improving outcomes in hematological malignancies.

Their new system is outlined in a paper published today in Nature Biomedical Engineering. CAR T cell therapy has revolutionized cancer care, providing a powerful option for some blood cancers.